Clinical experience with levofloxacin in the treatment of pneumonia in ICU patients.
Alvarez Lerma
F
F
Intensive Care Unit, Hospital del Mar, Barcelona, Spain. Falvarez@imas.imim.es
D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016001:Confidence Intervals; D016638:Critical Illness; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D007262:Infusions, Intravenous; D007362:Intensive Care Units; D064704:Levofloxacin; D008297:Male; D008826:Microbial Sensitivity Tests; D016017:Odds Ratio; D015242:Ofloxacin / Q000008:administration & dosage* / Q000009:adverse effects; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology* / Q000401:mortality; D011379:Prognosis; D018570:Risk Assessment; D013030:Spain; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D064704:Levofloxacin; D015242:Ofloxacin